Teleflex Incorporated (NYSE:TFX) Shares Sold by New York State Teachers Retirement System

New York State Teachers Retirement System trimmed its holdings in Teleflex Incorporated (NYSE:TFX) by 4.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 44,889 shares of the medical technology company’s stock after selling 2,225 shares during the quarter. New York State Teachers Retirement System owned 0.10% of Teleflex worth $11,193,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Allworth Financial LP lifted its stake in Teleflex by 332.3% during the third quarter. Allworth Financial LP now owns 134 shares of the medical technology company’s stock valued at $26,000 after buying an additional 103 shares in the last quarter. Venturi Wealth Management LLC purchased a new stake in Teleflex during the third quarter valued at about $27,000. Covestor Ltd lifted its stake in Teleflex by 305.6% during the third quarter. Covestor Ltd now owns 146 shares of the medical technology company’s stock valued at $29,000 after buying an additional 110 shares in the last quarter. Massmutual Trust Co. FSB ADV lifted its stake in Teleflex by 418.5% during the fourth quarter. Massmutual Trust Co. FSB ADV now owns 140 shares of the medical technology company’s stock valued at $35,000 after buying an additional 113 shares in the last quarter. Finally, ING Groep NV purchased a new stake in Teleflex during the third quarter valued at about $39,000. 95.62% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Teleflex

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of the stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $225.00, for a total transaction of $1,665,225.00. Following the transaction, the vice president now owns 10,050 shares in the company, valued at $2,261,250. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 1.41% of the company’s stock.

Teleflex Trading Down 2.5 %

NYSE:TFX opened at $218.24 on Thursday. The stock’s 50 day moving average price is $230.87 and its 200 day moving average price is $224.74. Teleflex Incorporated has a 52 week low of $177.63 and a 52 week high of $276.43. The company has a market capitalization of $10.28 billion, a P/E ratio of 28.98, a P/E/G ratio of 2.08 and a beta of 1.11. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.29 and a current ratio of 2.32.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 22nd. The medical technology company reported $3.38 EPS for the quarter, topping analysts’ consensus estimates of $3.26 by $0.12. Teleflex had a return on equity of 14.98% and a net margin of 11.98%. The firm had revenue of $773.90 million for the quarter, compared to the consensus estimate of $769.01 million. During the same quarter in the prior year, the company posted $3.52 earnings per share. The firm’s revenue was up 2.1% on a year-over-year basis. On average, research analysts forecast that Teleflex Incorporated will post 13.73 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $1.36 annualized dividend and a yield of 0.62%. Teleflex’s dividend payout ratio (DPR) is presently 18.06%.

Analyst Ratings Changes

A number of research firms have commented on TFX. Raymond James upped their price objective on shares of Teleflex from $227.00 to $271.00 and gave the company an “outperform” rating in a research note on Wednesday, December 20th. StockNews.com downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 23rd. Truist Financial dropped their target price on Teleflex from $270.00 to $265.00 and set a “hold” rating on the stock in a report on Friday, February 23rd. JMP Securities reiterated a “market outperform” rating and issued a $285.00 target price on shares of Teleflex in a report on Friday, February 23rd. Finally, Royal Bank of Canada dropped their target price on Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a report on Friday, February 23rd. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $265.56.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.